TrialJournal of pharmacokinetics and pharmacodynamics2012

Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach.

Leonid Gibiansky et al.PubMed ↗Publisher ↗

No numbers read from the abstract.